Stocks
ALX Oncology Holdings (ALXO) ROE US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 6 972% | 38.6% | 41.3% | 37.9% | -84.8% | -110.5% | ||
| Changes by years, y/y, % | +7 122pp | -6 934pp | +3pp | -3pp | -123pp | -10.8% | |||
ALX Oncology Holdings. ROE, %
ALX Oncology Holdings. ROE, changes, pp
ALX Oncology Holdings (ALXO) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | 32.8% | -83.9% | -101.2% | -107.6% | -110.5% | -110.5% | |
| Changes by years, y/y, % | +93pp | -121pp | -49pp | -48pp | -143pp | |||
| Changes by quarters, q/q, % | +93pp | -117pp | -17pp | -6pp | -3pp | |||
